Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New blood test may spare prostate cancer patients from unnecessary scans

NCT ID NCT07553754

First seen May 13, 2026 · Last updated Jun 18, 2026 · Updated 8 times

Summary

This study is developing a blood test that looks at genetic material (RNA) from tiny particles called exosomes to predict if prostate cancer has spread to the bones. The goal is to create a reliable 'rule-out' test so that low-risk patients can safely avoid more expensive and time-consuming PET scans. Researchers will study 1000 men with newly diagnosed prostate cancer to see how accurate this blood test is compared to standard imaging.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PSMA PET are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Affiliated Hospital of Yan'an University

    RECRUITING

    Yan’an, Shaanxi, China

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • General Hospital of Ningxia Medical University

    RECRUITING

    Yinchuan, Ningxia, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Qinghai University Affiliated Hospital

    RECRUITING

    Xining, Shaanxi, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Shaanxi Provincial People's Hospital

    RECRUITING

    Xi'an, Shaanxi, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • The First Hospital of Lanzhou University

    RECRUITING

    Lanzhou, Gansu, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • The Second Affiliated Hospital of Shaanxi University of Chinese Medicine

    RECRUITING

    Xianyang, Shaanxi, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Weinan Central Hospital

    RECRUITING

    Weinan, Shaanxi, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Xijing 986 Hospital

    RECRUITING

    Xi'an, Shaanxi, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Xijing Hospital

    RECRUITING

    Xi'an, Shaanxi, 710032, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

Conditions

The condition(s) this trial relates to.

disease metastatic carcinoma in the bone prostate cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.